Options
High-mobility group box protein 1: a novel mediator of inflammatory-induced renal epithelial-mesenchymal transition
Alternative Title
HMGB-1 - a novel mediator of inflammatory-induced renal epithelial mesenchymal transition
Date Issued
2010-11-24
Date Available
2012-06-12T14:17:43Z
Abstract
Background: High mobility group box protein 1 (HMGB-1) is a chromatin binding protein that bends DNA thereby facilitating gene transcription. HMGB-1 has also been observed as an extracellular secreted protein in serum of patients with sepsis and has putative intracellular signalling effects regulating the production of interleukin-1 and tumour necrosis factor in a number of inflammatory conditions.
Methods: We established a model of immune-mediated epithelial-mesenchymal transition (EMT) in human proximal tubular epithelial cells (PTECs). PTECs were cultured with conditioned medium containing supernatant from activated peripheral blood mononuclear cells (aPBMC). The model was characterised using phenotypic and transcriptomic approaches and suppression subtractive hybridisation was performed to identify differentially regulated genes.
Results. Activation of PBMCs resulted in increased secretion of HMGB-1. In addition, treatment of PTECs with aPBMC-conditioned medium resulted in significant upregulation of HMGB-1 in PTECs. Direct treatment of PTECs with recombinant human HMGB-1 induced alterations in epithelial morphology consistent with EMT including reduced E-cadherin expression, increased α-SMA expression and enhanced cell migration. HMGB-1 effects were mediated at least in part by the receptor for advanced glycation end products (RAGE) and through induction of TGF-β1 secretion from PTECs.
Conclusions. These results suggest that HMGB-1 is a key mediator of immune-mediated EMT of PTECs and a potentially important signalling molecule in the development of renal fibrosis.
Methods: We established a model of immune-mediated epithelial-mesenchymal transition (EMT) in human proximal tubular epithelial cells (PTECs). PTECs were cultured with conditioned medium containing supernatant from activated peripheral blood mononuclear cells (aPBMC). The model was characterised using phenotypic and transcriptomic approaches and suppression subtractive hybridisation was performed to identify differentially regulated genes.
Results. Activation of PBMCs resulted in increased secretion of HMGB-1. In addition, treatment of PTECs with aPBMC-conditioned medium resulted in significant upregulation of HMGB-1 in PTECs. Direct treatment of PTECs with recombinant human HMGB-1 induced alterations in epithelial morphology consistent with EMT including reduced E-cadherin expression, increased α-SMA expression and enhanced cell migration. HMGB-1 effects were mediated at least in part by the receptor for advanced glycation end products (RAGE) and through induction of TGF-β1 secretion from PTECs.
Conclusions. These results suggest that HMGB-1 is a key mediator of immune-mediated EMT of PTECs and a potentially important signalling molecule in the development of renal fibrosis.
Sponsorship
Science Foundation Ireland
Higher Education Authority
Health Research Board
Other funder
Other Sponsorship
Enterprise Ireland
Irish Nephrological Society
Amgen
Type of Material
Journal Article
Publisher
Karger
Journal
American Journal of Nephrology
Volume
32
Issue
6
Start Page
590
End Page
602
Copyright (Published Version)
2010 Karger
Subject – LCSH
Kidneys--Fibrosis
Chromosomal proteins
Blood cells
Transforming growth factors-beta
Language
English
Status of Item
Peer reviewed
This item is made available under a Creative Commons License
File(s)
Loading...
Name
HMGB1_NDT_2010_Draft.pdf
Size
1.04 MB
Format
Adobe PDF
Checksum (MD5)
a8bd0b282969cf0dbca1d53de5e51aa4
Owning collection